Areas of Expertise

Dr Hiva Fassihi performs a range of treatments including:

• General dermatology
• Photodermatology
• Phototherapy
• Mole checks

Some of the conditions she commonly treats are:

• Acne
• Eczema
• Rosacea
• Sun sensitive disorders

About Dr Hiva Fassihi

Dr Hiva Fassihi  is a Consultant Dermatologist at OneWelbeck Skin Health & Allergy and the Clinical Lead for the National XP (Xeroderma Pigmentosum) Service at St John’s Institute of Dermatology. Dr Fassihi consults on general dermatology, with specialist interests in genetic skin disorders and skin cancer.

She is an Honorary Senior Lecturer at King’s College, London and a Fellow of the Royal College of Physicians (FRCP) alongside being a member of the British Association of Dermatologists and British Society of Paediatric Dermatology.

Dr Fassihi is also a manuscript reviewer for the British Journal of Dermatology, and Clinical and Experimental Dermatology and has written numerous textbook chapters on dermatology. Additionally, she has achieved an array of awards for numerous of her presentations and papers including Albert M. Kligman Fellowship, Hugh Wallace Registrar’s prize, The Martin Beare Millennium Paediatric Award, Whimster Prize and Guys and St Thomas CARE award – XP team.

Dr Hiva Fassihi graduated from the University of Cambridge and undertook dermatology training at St John’s Institute of Dermatology, Guy’s and St Thomas’ London between 2003 – 2011.

This training included 3 years as a clinical research fellow working with the national epidermolysis bullosa service in where her research has led to numerous publications in highly regarded journals and presentations at both national and international dermatology and scientific meetings.

She was made an Honorary Clinical Senior Lecturer at King’s College, London in 2017.

Research Highlights

Dr Hiva Fassihi has achieved multiple publications in peer-reviewed journals:

Key Publications

• Lehmann AR, Fassihi H. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum. DNA Repair (Amst). 2020 Sep;93:102907.
• Cohen JI, Manoli I, Dowdell KC, Krogmann TA, Tamura D, Radecki P, Bu W, Turk SP, Liepshutz K, Hornung RL, Fassihi H, Sarkany RP FRCP, Bonnycastle LL, Chines PS, Swift AJ, Myers TG, Levoska MA, DiGiovanna JJ, Collins FS, Kraemer KH, Pittaluga S, Jaffe ES. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in Caucasians. Blood. 2019 Jun 27;133(26):2753-2764.
• Momen S, Fassihi H, Davies HR, Nikolaou C, Degasperi A, Stefanato CM, Dias JML, Dasgupta D, Craythorne E, Sarkany R, Papa S, Nik-Zainal S. Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease. Cold Spring Harb Mol Case Stud. 2019 Oct 23;5(5):a004408.
• Phan K, Ramachandran V, Fassihi H, Sebaratnam DF. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 Mar 1;155(3):335-341.
• Fityan A, McGibbon D, Fassihi H, Sarkany RS. Paediatric solar urticaria: a case series. Br J Dermatol. 2018 Jun;178(6):1453-1454.
• Chee SN, Novakovic L, Fassihi H, Garibaldinos T, Sarkany R. Chronic actinic dermatitis: successful treatment with psoralen-ultraviolet A photochemotherapy. Br J Dermatol. 2018 Mar;178(3):e189-e190.
• Fassihi H, Sethi M, Fawcett H, Wing JF, Chandler N, Mohammed S, Craythorne E, Morley ANS, Lim R, Turner S, Henshaw T, Garrood I, Giunti P, Hedderly T, Abiona A, Naik H, Harrop G, McGibbon D, Jaspers NG, Botta E, Nardo T, Stefanini M, Young AR, Sarkany RPE, Lehmann AR. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect. Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1236-45.
• Kashiyama K, Nakazawa Y, Pilz DT, Guo C, Shimada M, Sasaki K, Fawcett H, Wing JF, Lewin SO, Carr L, Li TS, Yoshiura K, Utani A, Hirano A, Yamashita S, Greenblatt D, Nardo T, Stefanini M, McGibbon D, Sarkany R, Fassihi H, Takahashi Y, Nagayama Y, Mitsutake N, Lehmann AR, Ogi T. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet. 2013 May 2;92(5):807-19.